[go: up one dir, main page]

EA201991933A1 - Лечение гингивита - Google Patents

Лечение гингивита

Info

Publication number
EA201991933A1
EA201991933A1 EA201991933A EA201991933A EA201991933A1 EA 201991933 A1 EA201991933 A1 EA 201991933A1 EA 201991933 A EA201991933 A EA 201991933A EA 201991933 A EA201991933 A EA 201991933A EA 201991933 A1 EA201991933 A1 EA 201991933A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oral
individual
oral cavity
gingivitis
need
Prior art date
Application number
EA201991933A
Other languages
English (en)
Inventor
Эрик Чарльз Рейнольдс
Original Assignee
Де Юниверсити Оф Мельбурн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900893A external-priority patent/AU2017900893A0/en
Application filed by Де Юниверсити Оф Мельбурн filed Critical Де Юниверсити Оф Мельбурн
Publication of EA201991933A1 publication Critical patent/EA201991933A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838—Phosphorus compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к композициям и их применению для ухода за полостью рта. В частности, эти композиции и способы предназначены для поддержания здоровья полости рта и/или лечения различных состояний полости рта, таких как гингивит. Настоящее изобретение относится к способам и применениям стабилизированного аморфного фосфата кальция (АСР) и/или стабилизированного аморфного фторида-фосфата кальция (ACFP) в изготовлении лекарственного средства для уменьшения количества патогенных бактерий полости рта на участке полости рта у индивида; увеличения количества комменсальных бактерий полости рта на участке полости рта у индивида; уменьшения доли патогенных бактерий полости рта на участке полости рта у индивида; ингибирования дисбиоза полости рта; уменьшения воспаления десен у индивида, нуждающегося в этом; лечения гингивита у индивида, нуждающегося в этом; и лечения хронического гингивита у индивида, нуждающегося в этом.
EA201991933A 2017-03-14 2018-03-14 Лечение гингивита EA201991933A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2017900893A AU2017900893A0 (en) 2017-03-14 Treatment for gingivitis
PCT/AU2018/050231 WO2018165708A1 (en) 2017-03-14 2018-03-14 Treatment for gingivitis

Publications (1)

Publication Number Publication Date
EA201991933A1 true EA201991933A1 (ru) 2020-03-05

Family

ID=63521651

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991933A EA201991933A1 (ru) 2017-03-14 2018-03-14 Лечение гингивита

Country Status (15)

Country Link
US (2) US11717536B2 (ru)
EP (2) EP4311576A3 (ru)
JP (1) JP7142943B2 (ru)
KR (2) KR102696078B1 (ru)
CN (1) CN110475533A (ru)
AU (2) AU2018233577B2 (ru)
CA (1) CA3055091A1 (ru)
EA (1) EA201991933A1 (ru)
ES (1) ES2975419T3 (ru)
MX (1) MX393086B (ru)
MY (1) MY197428A (ru)
PH (1) PH12019550157A1 (ru)
PL (1) PL3595615T3 (ru)
SG (2) SG10202110136XA (ru)
WO (1) WO2018165708A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2705826T3 (pl) 2006-02-09 2020-11-02 The University Of Melbourne Kompozycja fluorku i sposoby mineralizacji zębów
CA2918441C (en) 2013-07-23 2023-03-21 The University Of Melbourne A base and phosphopeptide stabilized amorphous calcium phosphate (acp) and/or amorphous calcium fluoride phosphate (acfp) for use in promoting remineralisation
EP3086751B1 (en) 2013-12-24 2023-07-12 The University Of Melbourne Stabilized stannous compositions
KR102696078B1 (ko) 2017-03-14 2024-08-16 더 유니버시티 오브 멜버른 치은염을 위한 치료
AU2018233576B2 (en) 2017-03-14 2021-06-24 The University Of Melbourne Complexes for treating sensitivity

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US746A (en) 1838-05-25 Improvement in the process of coloring hats, furs
US5112A (en) 1847-05-15 Cast-iron car-wheel
US5968A (en) 1848-12-12 Parlor-stove
US758A (en) 1838-05-30 Mode op
US122A (en) 1837-02-10 Improvement in the machine for weighing heavy bodies
US3864471A (en) 1968-12-20 1975-02-04 Colgate Palmolive Co Stable dentifrices containing a monofluorophosphate, an insoluble metaphosphate, and calcium carbonate
US3966901A (en) 1970-12-29 1976-06-29 Colgate-Palmolive Company Dentifrice preparation
US4080440A (en) 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4157386A (en) 1978-05-18 1979-06-05 Rochelle Paul J Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing
US4588763A (en) 1978-06-01 1986-05-13 Braennstroem Martin Ethyl acetate as solvent in cavity liners
NZ199891A (en) 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4357318A (en) 1981-07-31 1982-11-02 Richardson-Vicks Inc. Dentifrices with improved soluble fluoride availability
US4522805A (en) 1983-06-08 1985-06-11 Norman Gordon Tooth and gum dentifrice
US4672032A (en) 1983-11-09 1987-06-09 University Of Southern California Dental enamel production
CA1315480C (en) 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US5015628A (en) 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US6056930A (en) 1989-05-24 2000-05-02 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5227154A (en) 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
JP3762426B2 (ja) 1992-06-29 2006-04-05 ザ ユニヴァーシティ オブ メルボルン 過敏症の歯の治療
CH684773A5 (fr) 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
JP3471431B2 (ja) 1994-07-18 2003-12-02 株式会社ジーシー 歯科用グラスアイオノマーセメント組成物
JP3340265B2 (ja) 1994-11-21 2002-11-05 一枝 山岸 歯の漂白剤
KR0140248B1 (ko) 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
PT748591E (pt) 1995-06-16 2002-04-29 Nestle Sa Caseinas micelares fluoradas
US6036944A (en) 1995-08-08 2000-03-14 Enamelon, Inc. Processes for the remineralization and mineralization of teeth
JP2974604B2 (ja) 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP4040705B2 (ja) 1996-01-24 2008-01-30 株式会社サンギ 口腔組成物
AUPN898296A0 (en) 1996-03-28 1996-04-26 Nulite Systems International Pty Ltd Elastomeric state glass ionomer cement
US5741773A (en) 1996-04-26 1998-04-21 Colgate Palmolive Company Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant
JP2975337B2 (ja) 1997-02-20 1999-11-10 雪印乳業株式会社 カルシウム複合体
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
AUPO566297A0 (en) 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
JPH11228327A (ja) 1998-02-18 1999-08-24 Gc Corp 歯科用ペースト系グラスアイオノマーセメント組成物
JP3742523B2 (ja) 1998-02-27 2006-02-08 雪印乳業株式会社 高分子型カルシウム・ホスホペプチド複合体
US6120754A (en) 1998-03-11 2000-09-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Remineralization of teeth
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
CN1201720C (zh) 1999-03-25 2005-05-18 卡德伯里亚当斯美国有限责任公司 口腔保健用的口香糖和糖果
US6846500B1 (en) 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
FR2791573B1 (fr) 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
US6149894A (en) 1999-05-14 2000-11-21 Colgate Palmolive Company Method for the manufacture of toothpaste
US6521215B2 (en) 1999-05-28 2003-02-18 Devin Okay Compositions and methods for tooth treatment
US6685920B2 (en) 1999-11-12 2004-02-03 The Procter & Gamble Company Method of protecting teeth against erosion
JP2001144695A (ja) 1999-11-17 2001-05-25 Matsushita Electric Ind Co Ltd 音声処理装置及び音声処理方法
GB9929919D0 (en) 1999-12-17 2000-02-09 Hannah Research Inst The Calcium phosphate nanoclusters and their applications
US7727539B2 (en) 2001-03-14 2010-06-01 Drexel University Polymeric bioresorbable composites containing an amorphous calcium phosphate polymer ceramic for bone repair and replacement
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
CN100386065C (zh) 2002-01-03 2008-05-07 宝洁公司 包含酪蛋白磷酸肽复合物和氟化物的稳定的口腔用组合物
WO2003059303A2 (en) 2002-01-03 2003-07-24 The Procter & Gamble Company Stable oral compositions comprising casein phosphopeptide complexes and fluoride
NZ522071A (en) 2002-10-18 2005-07-29 Patrick Joseph Silcock Hydrolysed casein phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
JP3853785B2 (ja) 2002-12-27 2006-12-06 花王株式会社 口腔用組成物
DE60326998D1 (de) 2002-12-27 2009-05-14 Kao Corp Orale zubereitung
JP4340069B2 (ja) 2003-01-10 2009-10-07 雪印乳業株式会社 カルシウム複合体の製造法
US20050089481A1 (en) 2003-10-23 2005-04-28 Gc Corporation Composition for caries prevention
JP2005145952A (ja) 2003-10-23 2005-06-09 Gc Corp う蝕予防用組成物
US20050118115A1 (en) 2003-10-24 2005-06-02 Fontenot Mark G. Accelerated tooth whitening method, composition and kit
US20060183081A1 (en) 2004-09-27 2006-08-17 Al Bevilacqua Tooth bleaching system and method
AU2005309327B2 (en) 2004-11-25 2010-11-25 The University Of Melbourne Stabilized calcium phosphate complexes
US7380375B2 (en) 2004-12-14 2008-06-03 Rite-Hite Holding Corporation Alarm system for a loading dock
ES2399345T3 (es) 2005-06-07 2013-03-27 The University Of Melbourne Mineralización dental
BRPI0611976B1 (pt) 2005-06-24 2018-07-10 The University Of Melbourne Complexos iônicos
US20090016972A1 (en) 2005-11-25 2009-01-15 Tamazi Omarovich Manasherov Oral cavity care curative and prophylactic composition
US20070254260A1 (en) 2005-12-02 2007-11-01 Alden Wayne S Iv Oral care compositions, methods, devices and systems
PL2705826T3 (pl) 2006-02-09 2020-11-02 The University Of Melbourne Kompozycja fluorku i sposoby mineralizacji zębów
WO2008089066A1 (en) 2007-01-12 2008-07-24 Mcneil-Ppc, Inc. Mineralization toothpaste
PL2249784T3 (pl) 2008-02-08 2016-12-30 Produkt do higieny jamy ustnej i sposoby jego stosowania i wytwarzania
GB0807224D0 (en) 2008-04-21 2008-05-28 Univ Dundee Remineralisation of calcified tissue
US9849310B2 (en) 2008-06-24 2017-12-26 Dental Alliance Holdings, Llc Dental appliance, oral care product and method of preventing dental disease
US9226895B2 (en) 2008-07-30 2016-01-05 Ultradent Products, Inc. Methods and kits for cleaning and remineralizing teeth
JP2010047494A (ja) 2008-08-20 2010-03-04 Gc Corp 歯牙塗布用組成物
JP5437692B2 (ja) * 2009-04-30 2014-03-12 インターコンチネンタル グレート ブランズ エルエルシー チューインガム組成物、チューインガム製品、及びこれらの製造方法
RU2505280C2 (ru) 2009-05-18 2014-01-27 Колгейт-Палмолив Компани Композиции для орального применения, содержащие соединения полигуанидиния, и способы их получения и применения
JP4693191B2 (ja) 2009-08-06 2011-06-01 日本歯科薬品株式会社 口腔用剤
JP2011073983A (ja) 2009-09-29 2011-04-14 Gc Corp 歯牙塗布用組成物
JP2011162470A (ja) 2010-02-09 2011-08-25 Gc Corp 歯牙用被覆材
BR112012019844A2 (pt) 2010-02-12 2017-12-05 Theocorp Holding Co Llc metodos e composições para melhorar a resistência mecânica dos dentes
US9539445B2 (en) 2010-11-22 2017-01-10 Taipei Medical University Type of anion-containing calcium phosphate compound for dental remineralization
KR20140000710A (ko) * 2011-01-24 2014-01-03 바스프 에스이 구강 건강 증진 조성물
JP2013163656A (ja) 2012-02-10 2013-08-22 Gc Corp 歯磨剤
GB201202341D0 (en) 2012-02-10 2012-03-28 Periproducts Ltd Multicomponent oral care compostion
CA2918441C (en) 2013-07-23 2023-03-21 The University Of Melbourne A base and phosphopeptide stabilized amorphous calcium phosphate (acp) and/or amorphous calcium fluoride phosphate (acfp) for use in promoting remineralisation
EP3086751B1 (en) 2013-12-24 2023-07-12 The University Of Melbourne Stabilized stannous compositions
CA2972105A1 (en) 2014-12-24 2016-06-30 The University Of Melbourne Mineralization fluoride compositions
AU2018233576B2 (en) 2017-03-14 2021-06-24 The University Of Melbourne Complexes for treating sensitivity
KR102696078B1 (ko) 2017-03-14 2024-08-16 더 유니버시티 오브 멜버른 치은염을 위한 치료
AU2020234299C1 (en) 2019-03-13 2024-10-10 The University Of Melbourne Compositions and methods for promoting mineralization
MX2021011094A (es) 2019-03-13 2021-12-10 Univ Melbourne Ocultacion de lesiones hipomineralizadas.

Also Published As

Publication number Publication date
AU2018233577A1 (en) 2019-09-26
AU2021269317B2 (en) 2024-05-02
SG10202110136XA (en) 2021-10-28
US11717536B2 (en) 2023-08-08
KR102696078B1 (ko) 2024-08-16
PH12019550157A1 (en) 2020-06-15
KR20240055159A (ko) 2024-04-26
US20200054672A1 (en) 2020-02-20
BR112019018798A2 (pt) 2020-04-07
KR20190126141A (ko) 2019-11-08
JP2020514354A (ja) 2020-05-21
WO2018165708A1 (en) 2018-09-20
MX393086B (es) 2025-03-24
EP4311576A3 (en) 2024-04-10
MX2019010832A (es) 2019-10-30
EP3595615A4 (en) 2020-12-02
ES2975419T3 (es) 2024-07-05
CA3055091A1 (en) 2018-09-20
AU2021269317A1 (en) 2021-12-09
EP4311576A2 (en) 2024-01-31
PL3595615T3 (pl) 2024-05-13
US20240016836A1 (en) 2024-01-18
CN110475533A (zh) 2019-11-19
AU2018233577B2 (en) 2021-08-19
EP3595615B1 (en) 2024-01-10
MY197428A (en) 2023-06-16
JP7142943B2 (ja) 2022-09-28
EP3595615A1 (en) 2020-01-22
NZ757005A (en) 2023-08-25
SG11201907951QA (en) 2019-09-27

Similar Documents

Publication Publication Date Title
EA201991933A1 (ru) Лечение гингивита
EA201992878A1 (ru) Соединения для лечения болезни хантингтона
MX391850B (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
EA201890767A1 (ru) C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений
MX2015009991A (es) Composiciones y metodos.
PH12021551455A1 (en) Jak1 pathway inhibitors for the treatment of gastrointestinal disease
WO2016191389A3 (en) Compositions containing antimicrobial igy antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (ohc) microorganisms
ECSP12011962A (es) Tratamientos para trastornos gastrointestinales
NZ732241A (en) A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
CY1123532T1 (el) Αναστολεις του gingipain λυσινης
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
ZA202000375B (en) Compounds for the prevention and treatment of medical disorders and uses thereof
EA202091118A1 (ru) Антибактериальные соединения
EA202091446A1 (ru) Способы лечения хронических воспалительных заболеваний
CL2018000430A1 (es) Compuesto de hidroxitriazina y uso médico relacionado.
CY1116158T1 (el) Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
MX2022013283A (es) Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales.
EA201792085A1 (ru) Смешанные дисульфидные конъюгаты тиенопиридиновых соединений и их применение
ZA201906153B (en) Pharmaceutical compositions for combination therapy
EA201692051A1 (ru) Арилзамещенные гетероциклилсульфоны
BR112016029619A2 (pt) novas fluoroquinolonas e sesu usos no tratamento de infecções bacterianas
MX2023010918A (es) Metodos y composiciones para el tratamiento de enfermedades oculares.
CY1118255T1 (el) Υποκατεστημενα 6-αμινο-νικοτιναμιδια τα οποια φερουν μια ομαδα που περιεχει οη ως διαμορφωτες των kcnq2/3
EA201890911A1 (ru) Комбинация тразодона и габапентина для лечения боли
MX2015015467A (es) Metodos y tratamiento para ciertos trastornos basados en desmielizacion y desmielizacion y/o que promueven la remielinizacion.